Tag: Antitoxins

The American Society for Microbiology’s ASM Biothreats 2018 meeting is taking place February 12-14, 2018 in Baltimore, Maryland. ASM Biothreats ...

The Biomedical Advanced Research and Development Authority (BARDA) is soliciting proposals for the advanced research and development of medical countermeasures ...

The Nonclinical Studies Network is a key element in the successful development of U.S. medical countermeasures for biological threats, particularly ...

The 2016 Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Strategy and Implementation Plan (SIP), released this week by the U.S. Department ...

Health Canada has approved the Emergent BioSolutions Inc. New Drug Submission (NDS) for its botulism antitoxin, BAT® . BAT is ...

The National Institutes of Health (NIH) has awarded Rutgers University a five-year grant for more than $19 million for research ...

The U.S. federal government’s Countermeasures Against Chemical Threats (CounterACT) program is a research program supporting basic, translational, and clinical research aimed ...

In cases of natural or engineered disasters, such as a terrorist attack, influenza pandemic, or earthquake, state or local authorities ...

The U.S. Army's Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) has again chosen Battelle to perform critical medical ...

The Biomedical Advanced Research and Development Authority (BARDA) has identified continuous manufacturing (CM) as an emerging technology within the pharmaceutical ...

Anthrax Bacteria - Bacillus Anthracis Elusys Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved ...

Powered by the Lawrence Livermore National Laboratory’s supercomputers, researchers are simulating the energy requirements for candidate drug molecules to permeate ...

Sustaining public and private investment in the development of medical countermeasures before an emerging infectious disease becomes a public health ...

The Joint Project Manager for Medical Countermeasure Systems (JPM-MCS) through the Joint Program Executive Office for Chemical and Biological Defense ...

U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response will host a Public ...

Military program managers briefed biopharmaceutical industry and research organization representatives during a Nov. 2 Industry Day, part of an initiative ...

The U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) this week ...

The National Institutes of Health (NIH) CounterACT program fosters and supports research and development of new and improved therapeutics for ...

The U.S. federal government has recently extended the period of performance on three Research and Development contracts in support of ...